Silo Pharma annual r&d spending
2020
2021
2022
2023
2024
2025
Silo Pharma R&D Spending Growth & History (SILO)
Silo Pharma's r&d spending was $2.2M for fiscal 2025.
View full Silo Pharma company overviewSilo Pharma annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.2M | −$207,327 | −8.75% |
| 2024 | 2024-12-31 | $2.4M | $1.5M | +180.22% |
| 2023 | 2023-12-31 | $845,092 | −$441,342 | −34.31% |
| 2022 | 2022-12-31 | $1.3M | $592,524 | +85.39% |
| 2021 | 2021-12-31 | $693,910 | $667,660 | +2543.47% |
| 2020 | 2020-12-31 | $26,250 | — | — |
Silo Pharma quarterly r&d spending
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $298,418 | −$418,829 | −58.39% |
| Q1 2026 | 2026-03-31 | $1.0M | $419,303 | +70.59% |
| Q4 2025 | 2025-12-31 | $306,005 | −$833,539 | −73.15% |
| Q3 2025 | 2025-09-30 | $543,615 | $26,067 | +5.04% |
| Q2 2025 | 2025-06-30 | $717,247 | $324,423 | +82.59% |
| Q1 2025 | 2025-03-31 | $593,962 | $275,722 | +86.64% |
| Q4 2024 | 2024-12-31 | $1.1M | $802,579 | +238.18% |
| Q3 2024 | 2024-09-30 | $517,548 | $343,053 | +196.60% |
| Q2 2024 | 2024-06-30 | $392,824 | $262,105 | +200.51% |
| Q1 2024 | 2024-03-31 | $318,240 | $115,327 | +56.84% |
| Q4 2023 | 2023-12-31 | $336,965 | −$297,719 | −46.91% |
| Q3 2023 | 2023-09-30 | $174,495 | −$201,300 | −53.57% |
| Q2 2023 | 2023-06-30 | $130,719 | $25,043 | +23.70% |
| Q1 2023 | 2023-03-31 | $202,913 | $32,634 | +19.17% |
| Q4 2022 | 2022-12-31 | $634,684 | $158,736 | +33.35% |
| Q3 2022 | 2022-09-30 | $375,795 | $305,281 | +432.94% |
| Q2 2022 | 2022-06-30 | $105,676 | $6,830 | +6.91% |
| Q1 2022 | 2022-03-31 | $170,279 | $121,677 | +250.35% |
| Q4 2021 | 2021-12-31 | $475,948 | — | — |
| Q3 2021 | 2021-09-30 | $70,514 | — | — |
| Q2 2021 | 2021-06-30 | $98,846 | — | — |
| Q1 2021 | 2021-03-31 | $48,602 | — | — |
Silo Pharma r&d spending trends
Over the last five fiscal years, Silo Pharma's r&d spending increased from $26,250 to $2.2M, a change of $2.1M. The latest reported quarter, Q2 2026, shows $298,418.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Silo Pharma source filings ↗